Global Orthopedics Conference 2025

On April 24, 2025, the inaugural Global Orthopedics Conference (GOC2025) was grandly held at the Zhongguancun National Innovation Demonstration Zone Exhibition Center in Beijing.

Co-hosted by BoneFuture, OrthoInsight and Siyu MedTech, and co-organized by Zhongguancun Lianxin Biomedical Industry Alliance, Beijing Zhongguancun Science City Innovation Development Co., Ltd., TusStar, Beijing Zhongguancun Venture Street Technology Service Co., Ltd., and Zhongguancun Science City CGT Industry Incubation Center, the event drew more than 600 clinical specialists, research scholars, corporate representatives and investors nationwide. Participants engaged in in-depth exchanges on hot topics including orthopedic technological innovation, medicine-engineering integration, volume-based procurement policies, and surgical robots.

High-Profile Opening: Tripartite Collaboration among Government, Hospitals and Media

The opening ceremony was presided over by Zhao Qing, Founder of Siyu MedTech, Editor-in-Chief of BoneFuture and Secretary-General of Zhongguancun Lianxin Biomedical Industry Alliance.

At the opening ceremony, Lin Hang, Deputy District Chief of Haidian District, Beijing, stated that Haidian will adopt more open mechanisms and targeted services to support orthopedic innovation. It aims to facilitate promising products such as orthopedic robots and biomaterials to grow from clinical needs, originate in Haidian, and reach markets nationwide.

Liu Hui, Director of the Beijing Center for Medical and Health Science and Technology Development, noted that Beijing is advancing a clinical-demand-driven sci-tech innovation system through policy guidance, platform development and coordinated governance across healthcare, medical insurance and pharmaceutical sectors. She said Beijing is supporting high-end medical devices like orthopedic implants to move from independent R&D to translation, with efficient services and systematic support to continuously fuel medicine-engineering integration and industrial upgrading.

Professor Wu Xinbao from Beijing Jishuitan Hospital also delivered opening remarks, commenting that the conference responds fully to the strong demand for orthopedic technological innovation from frontline clinical practice.

White Paper Launch & Three Major Awards Unveiled: A Showcase of Innovative Achievements

The conference officially released the 2025 Global Orthopedics Innovation Annual White Paper. The document systematically maps orthopedic medical device portfolios and technology trends, identifying new materials, surgical robots and AI-enabled orthopedics as core innovation priorities. Zhao Qing also introduced Siyu MedTech’s global content portfolio and the conference’s official English website, which will present cutting-edge Chinese medtech developments to global audiences going forward.

The award ceremony for the Global Orthopedics Innovation Awards marked a highlight of the agenda. Three prestigious award categories recognized enterprises with outstanding performance in technological breakthroughs, clinical adoption and service system development.

• Global Orthopedics Technology Innovation Award: 8 recipients, including Luosenbot, GORI Tech, Longmarch, Innoco, Stryker, Sinovision, Wanjie Tianyuan and Ansong Medical.

• Global Orthopedics Innovation Service Award: 5 recipients, including Tonghe Litai, GaoWo, Yingwei Medical, Huamai Medical and Susheng Bio.

• Global Orthopedics Clinical Application Award: 4 recipients, including Taodao Medical, Linyan Medical, Baioregen and Kangxi Bio.

Policy Briefings to Fuel Innovation and Support End-to-End Translation

Huang Rongjian, Second-Class Researcher at the Medical Device Registration Division of Beijing Medical Products Administration, delivered an in-depth interpretation of Beijing’s supportive policies for medical device innovation. She explained that Beijing operates a three-in-one framework featuring project-based management, end-to-end mentoring and expedited pathways, to accelerate the registration, approval and clinical rollout of innovative devices. With dual hubs in northern and southern Beijing, dedicated specialists and streamlined workflows, Beijing has built an efficient support network covering Class II and Class III medical devices, empowering high-end orthopedic products to evolve from clinical needs to rapid real-world delivery.

Cheng Wanhui, Director of the 3rd Industrial Promotion Division of the Zhongguancun Science City Administrative Committee, shared that Haidian is building a full-chain innovation ecosystem for medical and health industries. Driven by policy, data and real-world application scenarios, the framework creates efficient pathways from proof-of-concept to commercialization for next-generation medical devices.

Insight-Packed Keynote Presentations with Rich Industry Takeaways

The conference featured a dense lineup of keynote speeches from leading hospital specialists and industry innovators, covering frontline clinical practice and emerging technologies. The morning main forum was hosted by Wang Yu, Associate Professor at the School of Biological Science and Medical Engineering, Beihang University, and CEO of Luosenbot.

Professor Wu Xinbao, Vice President of Beijing Jishuitan Hospital, presented Transforming Fracture Care with Robotic Systems. He argued that trauma orthopedic robots should not be viewed merely as intraoperative tools, but as systemic platforms that reshape the philosophy of fracture management. They enable anatomical precision and accelerated recovery, moving care away from large incisions, difficult reduction and prolonged rehabilitation. With expanding use cases including remote operation and emergency fracture reduction in ICUs, orthopedic robots are driving fundamental transformation in trauma treatment models.

Professor Zhao Yu, Attending Orthopedic Surgeon at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, delivered Human Factors Engineering in Orthopedic Device Development. He noted that as orthopedic devices grow more complex and versatile, human factors engineering has become a core design principle for medical devices. Integrating behavioral characteristics of surgeons and patients systematically improves device safety and translation success rates, and provides a methodological foundation for domestic high-end equipment to build usability advantages.

Liu Jianxun, Senior Vice President & Head of Product Innovation at GORI Tech, presented Innovation for the Future: Next-Gen Intelligent Diagnosis and Treatment Robots Empowered by Large Models. As minimally invasive orthopedic surgery becomes more refined, conventional manual workflows struggle to coordinate complex multi-dimensional surgical procedures. GORI’s Newton intelligent diagnosis and treatment platform integrates intraoperative navigation, dual-arm collaboration and large AI models, advancing orthopedic robots from standalone tools toward full-process systemic platforms.

Shi Chen, CEO of Innoco, shared From Lab to Operating Room: R&D and Translation of ChroMg™ Chrono-Absorbable Magnesium Alloys. He stated that the core of orthopedic materials innovation lies in precise alignment with biological rhythms. The team’s ChroMg™ absorbable magnesium alloys open new pathways from materials engineering to clinical use, offering a benchmark for high-performance domestic implants entering real-world practice.

Li Yingjun, General Manager of Tonghe Litai and Chair of the Expert Committee on Medical Animal Experiments of the Chinese Research Hospital Association, presented General Framework for Innovative Research on Orthopedic Medical Devices. He maintained that sustainable device innovation requires dynamic balance among genuine clinical needs, mature technical roadmaps and industrial delivery capacity. Animal testing platforms serve as critical levers to boost verification efficiency and speed up translation.

Zhang Yiling, Chairman of Longmarch Medical, delivered High-End Medical Equipment including Orthopedic AI and Surgical Robots for High-Quality Development of the Big Health Industry. Orthopedic surgical robots are evolving from assistive tools into intelligent platforms centered on AI, covering preoperative image modeling, intraoperative dynamic osteotomy and postoperative structural validation to deliver personalized, precise, safe and efficient treatment. He emphasized that advances in domestic intelligent robotic systems represent not only engineering breakthroughs, but also a landmark step for Chinese orthopedics to pursue global leadership amid the new-quality productivity transition.

The morning roundtable, also hosted by Wang Yu from Luosenbot, explored the future of orthopedic devices across medicine-engineering integration, new materials, robotics and normalized volume-based procurement. Five panelists from research institutes, leading orthopedic device manufacturers, medtech investment platforms and clinical service providers discussed priorities for the next phase of orthopedic innovation.

Zhang Weijun, Director of Research Collaboration at Tinavi, observed that as orthopedic surgeries grow more complex, robots are evolving from auxiliary tools toward intelligent surgical platforms. Future technological breakthroughs will center on deep integration of high-precision perception, navigation algorithms and intraoperative feedback systems.

Tian Na, Deputy General Manager of the Beijing Naton Medical Research Institute, shared R&D progress on absorbable orthopedic materials and ceramic joints from a materials perspective. She stressed that materials innovation requires co-creation with surgeons; feeding intraoperative feedback back to engineering teams is essential to lift translation rates.

Xie Fengbao, Board Secretary of Chunli Medical, commented that amid normalized volume-based procurement, enterprises should focus on systematic value delivery. They need to control costs while strengthening technical moats and procedural innovation to improve product differentiation.

Wang Zaicun, Chief Analyst covering medical devices and services at CITIC Securities, analyzed the landscape from an investment perspective. While capital markets have adopted more rational valuation frameworks for medtech, well-defined, high-barrier product pipelines still enjoy solid financing prospects. He advised companies to communicate clearly their technical translation capacity and real clinical value to investors.

Hou Shuqiang, Deputy General Manager & Sales Director of Ansong Medical, representing emerging domestic orthopedic consumables brands, noted expanding opportunities in lower-tier markets for local players. To achieve high-quality growth, brands must bridge gaps in technical communication and surgeon education.

The lively, data-rich discussion offered multi-angle insights into trends in orthopedic devices, and validated the decisive role of the four-way collaboration of technology, clinical practice, policy and capital in shaping the sector.

The afternoon session continued with a packed agenda, chaired by Su Nan, Attending Physician at Beijing Friendship Hospital, Capital Medical University.

Jiang Shengli, Marketing Manager at Stryker, presented From Casting to Intelligent Manufacturing: Robot-Driven Precision Fabrication of 3D-Printed Prostheses. He explained that the Mako robotic system paired with custom 3D-printed implants is reshaping the full workflow of orthopedic replacement surgery, shifting from standardized manufacturing to intelligent, personalized reconstruction and ushering in an era of precise matching and accelerated rehabilitation.

Zhang Jinzhi from Beijing GaoWo Law Firm delivered Intellectual Property Protection for Medical Device Enterprises from a Patent Perspective. Amid intensifying competition in this technology-intensive sector, orthopedic device firms need to move from isolated patent filings to systematic IP layout. Robust high-value patent assessment and design-around strategies help build defensive and exclusive IP portfolios that support high-quality industrial translation of innovations.

Liu Tao, Deputy Director of the Emergency Medicine Center, Qilu Hospital (Qingdao), Shandong University, shared Surgical Management of Distal Radius Fractures: Development and Adoption of Innovative Technologies. With clinical case studies, he demonstrated how incremental device refinement, surgical iteration and workflow design can improve the replicability of common procedures at grassroots hospitals and enhance patient postoperative comfort. This embodies the bottom-up innovation model rooted in real clinical challenges.

Rui Biyu, Associate Chief Physician in Trauma Orthopedics at Shanghai Sixth People’s Hospital, presented Trauma Center Development in the New Technology Era. Modern trauma care upgrade relies not only on hardware upgrades but also on orthopedics-led multidisciplinary collaboration. By building composite emergency units, adopting a 120-minute treatment target and establishing fast-track pathways for geriatric trauma, the hospital is developing a replicable regional trauma care model as a national benchmark.

Zhou Yixin, Director of Orthopedic Reconstruction Center (Bone & Joint Disease Clinic), Beijing Jishuitan Hospital, shared Interaction between Implantation Technique and Implants: Establishing Interpretive Total Knee Arthroplasty. He proposed that titrated TKA represents a new paradigm for knee replacement, shifting from static implant design to dynamic regulation. Surgical robots enable real-time adjustment of osteotomy and soft tissue tension intraoperatively, aligning prosthesis geometry with individual kinematics and bringing personalized implantation into an era of integrated optimization of structure, parameters and strategy.

Lu Ming, Associate Chief Physician in Pediatric Orthopedics at Beijing Jishuitan Hospital, presented R&D and Application Outlook of Magnetically Driven Class III Active Orthopedic Implants. Together with Tsinghua University, his team has developed a magnetically controlled intramedullary lengthening system that transforms treatment workflows for orthopedic deformity correction and limb lengthening. Breaking international technological barriers, the system features minimally invasive access, high controllability and domestic affordability, standing as a model of medicine-engineering collaboration driven by unmet patient needs and industrial strategic priorities.

Su Nan, Attending Physician at Beijing Friendship Hospital, Capital Medical University, delivered Perspectives on the Future of Spinal Surgical Robots. Spinal robots are transitioning beyond auxiliary screw placement toward integrated procedural platforms. Next-generation products need to improve not only accuracy, but also support minimally invasive approaches, streamline intraoperative workflows and enhance surgeon experience, so that clinicians can adopt them confidently and routinely for patient benefit.

Tian Yun, Attending Trauma Orthopedic Surgeon and Director of the Medical Engineering Department at Peking University Third Hospital, shared 3D Printing Technology and Its Orthopedic Applications. The value of 3D printing extends beyond fabrication to system integration. Mimicking trabecular stress environments with porous structures and combining them with intramedullary nails and fixation plates, his team has achieved long-term stable reconstruction in complex limb bone defect cases, setting a benchmark for integrated innovation linking engineering, clinical practice and regulators.

Zhang Zhuo, Associate Chief Physician in Joint Surgery at Chinese PLA General Hospital, presented Medicine-Engineering Integration through the Eyes of an Orthopedic Surgeon. The key to successful collaboration today is not novelty of technology, but viable translation pathways. Closing the loop between clinical requirements and product development can build a translatable, scalable and sustainable innovation ecosystem and chart an independent development path for Chinese orthopedic devices.

Xing Gengyan, Attending Physician at the Third Medical Center of Chinese PLA General Hospital, shared Extracorporeal Shockwave Therapy Robots and Their Transdermal Drug Delivery Systems. The shockwave robotic platform breaks technical boundaries between non-invasive therapy, image navigation and smart drug release, redefining treatment paradigms for chronic orthopedic conditions and rehabilitation. With multimodal sensing and targeted precise delivery, it has potential to become an intelligent minimally invasive hub bridging physical therapy and deep tissue targeted intervention.

Zhao Minwei, Associate Chief Physician and Deputy Director of the Joint Surgery Subspecialty at Peking University Third Hospital, delivered The New Orthopedic Era Enabled by Digitalization. Orthopedics is moving from isolated device innovation toward intelligent coordination. By combining AI, digital twins and 3D printing, his team is building a closed digital workflow covering preoperative modeling, intraoperative navigation and postoperative assessment, turning precision medicine engineering concepts into understandable, usable and repeatable clinical tools for surgeons.

Conclusion: Medicine-Engineering Integration for a Shared Future

From white paper release and policy briefings to innovation awards, technical presentations and panel debates, GOC2025 featured a rich, forward-looking agenda and distinguished faculty, fully demonstrating the vitality of China’s orthopedic innovation ecosystem. Driven by the combined force of technology, clinical practice, policy and capital, outputs from medicine-engineering collaboration are accelerating into real-world deployment. The inaugural Global Orthopedics Conference is more than an exchange forum — it is a rallying point for innovators. The future of orthopedics starts here.